WILMINGTON, N.C., Jan. 26, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Canaccord Genuity Musculoskeletal Conference in San Francisco, CA on Tuesday, February 7, 2012 at 3 p.m. PT. Mr. Reali and Mr. Slattery will discuss the Company and its progress toward gaining market share with its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region and will also conduct one-on-one meetings with institutional investors. Investors that wish to request a meeting with TranS1 should contact Canaccord Genuity.
About TranS1 Inc.
TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and two level lumbar fusion and the Vectre and Avatar posterior fixation systems for lumbar fixation supplemental to AxiaLIF fusion. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit www.trans1.com.